Synapse Biomedical Inc. (SBI) was founded in September 2002 to commercialize the NeuRx® Diaphragm Pacing System (DPS) which has been developed during a twenty-year period, in collaboration with Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in state-of-the-art electrical stimulation for the treatment of chronic respiratory insufficiency.
Our culture is best described by its people: smart, driven, energetic and committed to improve the lives of individuals with neurological impairment, such as spinal cord injury, Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease and others.